In the United States, the capacity to perform diagnostic testing—or the absence of resources needed to do so—has become a critical concern for public health authorities trying to manage the covid-19 pandemic. In spite of assurances from senior health authorities, both healthcare providers and labs have continued to report shortages in the test kits and related equipment needed to support an aggressive program of population surveillance and patient diagnosis.
CLP is conducting this survey in order to understand how clinical labs are responding to the challenges of covid-19 testing. We would appreciate your participation so that the survey results can be as broadly representative of the lab community as possible.
Thank you in advance for your responses.
Featured image: Microphotograph of novel coronavirus SARS-CoV-2. Microphotograph by Elizabeth Fischer, Rocky Mountain Laboratory, National Institute for Allergy and Infectious Diseases.
